Evaluation of the epidemiological and economic impact of the ADLIFE intervention on medium- to long-term in patients with advanced chronic disease. - Larrañaga I; Mar J; Gorostiza A; García-Lorenzo B; Zubeltzu B; Vega R; Kaye R; Levy G; Vishnevetsky O; Lyngholm Christensen R; Dichmann Sorknæs A; Garton N; et al. (Frontiers in public health, 2025)